PT830376E - Processo de producao de eritropoietina isenta de proteinas animais - Google Patents

Processo de producao de eritropoietina isenta de proteinas animais

Info

Publication number
PT830376E
PT830376E PT96919753T PT96919753T PT830376E PT 830376 E PT830376 E PT 830376E PT 96919753 T PT96919753 T PT 96919753T PT 96919753 T PT96919753 T PT 96919753T PT 830376 E PT830376 E PT 830376E
Authority
PT
Portugal
Prior art keywords
free
eritropoietine
production process
host cell
animal proteins
Prior art date
Application number
PT96919753T
Other languages
English (en)
Inventor
Josef Burg
Walter Schneider
Alexander Wrba
Werner Furst
Karl-Heinz Sellinger
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of PT830376E publication Critical patent/PT830376E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT96919753T 1995-05-11 1996-05-10 Processo de producao de eritropoietina isenta de proteinas animais PT830376E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95107165 1995-05-11
DE19522461 1995-06-21

Publications (1)

Publication Number Publication Date
PT830376E true PT830376E (pt) 2004-05-31

Family

ID=26016131

Family Applications (2)

Application Number Title Priority Date Filing Date
PT03016548T PT1394179E (pt) 1995-05-11 1996-05-10 Processo para a produção de eritropoietina isenta de proteínas animais
PT96919753T PT830376E (pt) 1995-05-11 1996-05-10 Processo de producao de eritropoietina isenta de proteinas animais

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT03016548T PT1394179E (pt) 1995-05-11 1996-05-10 Processo para a produção de eritropoietina isenta de proteínas animais

Country Status (12)

Country Link
US (2) US6399333B1 (pt)
EP (2) EP1394179B1 (pt)
JP (1) JP3061200B2 (pt)
AT (2) ATE258189T1 (pt)
AU (1) AU5817496A (pt)
CA (1) CA2220515C (pt)
DE (2) DE59611371D1 (pt)
DK (2) DK0830376T3 (pt)
ES (2) ES2268232T3 (pt)
IL (2) IL118201A (pt)
PT (2) PT1394179E (pt)
WO (1) WO1996035718A1 (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU729459B2 (en) * 1996-11-15 2001-02-01 Genentech Inc. Purification of neurotrophins
JP4541539B2 (ja) * 1997-07-23 2010-09-08 ロシュ ダイアグノスティックス ゲーエムベーハー 内因性遺伝子活性化によるエリスロポエチンの製造
US6548296B1 (en) * 1997-07-23 2003-04-15 Roche Diagnostics Gmbh Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof
WO1999028346A1 (de) 1997-12-03 1999-06-10 Roche Diagnostics Gmbh Erythropoietin mit hoher spezifischer aktivität
NZ507557A (en) 1998-05-06 2003-10-31 Genentech Inc Protein purification by ion exchange chromatography
BR9917606A (pt) * 1998-11-06 2002-12-31 Bio Sidus S A Procedimento para a purificação de eritropoetina humana recombinante a partir de sobrenadantes de cultivo de células e eritropoetina humana recombinante obtida com tal procedimento
BR9905868A (pt) 1998-11-06 2001-01-23 Bio Sidus S A Procedimento de cultivo massivo de células de mamìfero para a obtenção de eritropoetina humana, recombinante e a eritropoetina humana recombinante obtida com tal procedimento
BR9905867A (pt) * 1998-11-06 2001-01-23 Bio Sidus S A Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula
JO2291B1 (en) 1999-07-02 2005-09-12 اف . هوفمان لاروش ايه جي Erythropoietin derivatives
AU2002233230B2 (en) 2000-12-20 2007-02-01 F. Hoffmann-La Roche Ag Erythropoietin conjugates
CN1596310A (zh) * 2001-11-28 2005-03-16 桑多斯有限公司 产生重组多肽的方法
ATE363541T1 (de) * 2002-03-26 2007-06-15 Lek Tovarna Farmacevtskih Verfahren für die herstellung eines gewünschten profils von erythropoietin glyko-isoformen
DE60228460D1 (de) * 2002-12-13 2008-10-02 Bioceuticals Arzneimittel Ag Verfahren zur Herstellung und Reinigung von Erythropoietin
US20050019914A1 (en) * 2003-07-24 2005-01-27 Aventis Pharma Deutschland Gmbh Perfusion process for producing erythropoietin
EP1670821A4 (en) * 2003-10-09 2006-11-29 Daewoong Co Ltd PROCESS FOR PURIFYING HUMAN THROMBOPOIETIN WITH HIGH SIALIC ACID CONTENT
DE102004027816A1 (de) * 2004-06-08 2006-01-05 Bioceuticals Arzneimittel Ag Verfahren zur Reinigung von Erythropoietin
US7598356B2 (en) * 2004-07-08 2009-10-06 Board of Regents of the University of Nebraska by and on behalf of the University of Nebraska Medical Center Method for purifying a protein of the cystine-knot superfamily
DE602004013847D1 (de) * 2004-11-09 2008-06-26 Usv Ltd Neues verfahren zur aufreinigung von humanem wachstumshormon
ES2509872T3 (es) * 2005-03-03 2014-10-20 Allergan, Inc. Procedimientos para obtener una toxina clostrídica
EP2495308A1 (en) 2005-12-08 2012-09-05 Amgen Inc. Improved production of glycoproteins using manganese
PL2054074T3 (pl) 2006-08-04 2015-03-31 Prolong Pharmaceuticals Llc Zmodyfikowana erytropoetyna
EP2089424B1 (en) * 2006-12-06 2015-07-01 JCR PHARMACEUTICALS Co., LTD. Method for production of human erythropoietin
KR100988706B1 (ko) 2007-03-07 2010-10-18 한미홀딩스 주식회사 재조합 에리트로포이에틴의 신규한 정제방법
CL2008002053A1 (es) 2007-07-17 2009-05-22 Hoffmann La Roche Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
AR067536A1 (es) * 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
KR100900033B1 (ko) 2007-11-21 2009-06-01 한국생명공학연구원 인간 에리스로포이에틴의 정제방법
MX344166B (es) 2008-02-08 2016-12-07 Ambrx Inc Leptina-polipeptidos modificados y sus usos.
DE102008002210A1 (de) * 2008-06-04 2009-12-10 Evonik Degussa Gmbh Verfahren zur fermentativen Herstellung von Erythropoietin
DE102008002209A1 (de) 2008-06-04 2009-12-10 Evonik Degussa Gmbh Verfahren zur Aufreinigung von Erythropoietin
CN102164954B (zh) 2008-09-23 2018-04-06 弗·哈夫曼-拉罗切有限公司 促红细胞生成素的纯化
BR122012024318A2 (pt) 2008-09-26 2019-07-30 Ambrx, Inc. Polipeptídeos modificados de eritropoetina animal e seus usos
DE102008054716A1 (de) 2008-12-16 2010-06-17 Evonik Degussa Gmbh Inprozesskontrolle in einem Verfahren zur Herstellung von EPO
US20120177640A1 (en) 2009-07-24 2012-07-12 Josef Burg Optimizing the production of antibodies
EA022396B1 (ru) 2009-09-23 2015-12-30 Ратиофарм Гмбх Способ очистки рекомбинантного эритропоэтина человека (epo), эритропоэтин, очищенный данным способом, и фармацевтические композиции, содержащие такой эритропоэтин
KR101443257B1 (ko) * 2011-10-18 2014-09-19 주식회사 종근당 낮은 등전점을 갖는 에리스로포이에틴 유사체의 정제방법
US10066001B2 (en) 2013-03-15 2018-09-04 Apotex Inc. Enhanced liquid formulation stability of erythropoietin alpha through purification processing
WO2016116966A1 (en) * 2015-01-22 2016-07-28 Jcr Pharmaceuticals Co., Ltd. Method for purification of recombinant human alpha-galactosidase a from material containing contaminant host cell proteins
DK3613486T3 (da) * 2018-08-24 2021-01-04 Uga Biopharma Gmbh Metode og anlæg til rengøring af epo og/eller et epo-derivat

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4677195A (en) * 1985-01-11 1987-06-30 Genetics Institute, Inc. Method for the purification of erythropoietin and erythropoietin compositions
IL79176A (en) * 1985-06-20 1992-06-21 Kirin Amgen Inc Process for the recovery of erythropoietin from a fluid
US4954437A (en) * 1986-09-15 1990-09-04 Integrated Genetics, Inc. Cell encoding recombinant human erythropoietin
AU4104889A (en) 1988-09-07 1990-03-15 Bioclones (Pty) Ltd Purification of erythropoietin
DE4115722A1 (de) * 1991-05-14 1992-11-19 Boehringer Mannheim Gmbh Serumfreies medium zur kultivierung von saeugerzellen

Also Published As

Publication number Publication date
IL118201A0 (en) 1996-09-12
DK0830376T3 (da) 2004-05-24
PT1394179E (pt) 2006-11-30
DE59610898D1 (de) 2004-02-26
WO1996035718A1 (de) 1996-11-14
JP3061200B2 (ja) 2000-07-10
JPH10506924A (ja) 1998-07-07
ATE334146T1 (de) 2006-08-15
ATE258189T1 (de) 2004-02-15
CA2220515C (en) 2003-07-22
EP1394179A1 (de) 2004-03-03
EP0830376B1 (de) 2004-01-21
US6471500B1 (en) 2002-10-29
ES2211961T3 (es) 2004-07-16
AU5817496A (en) 1996-11-29
IL157644A0 (en) 2004-03-28
DK1394179T3 (da) 2006-11-20
US20020146771A1 (en) 2002-10-10
IL118201A (en) 2004-12-15
EP1394179B1 (de) 2006-07-26
CA2220515A1 (en) 1996-11-14
DE59611371D1 (de) 2006-09-07
EP0830376A1 (de) 1998-03-25
ES2268232T3 (es) 2007-03-16
US6399333B1 (en) 2002-06-04

Similar Documents

Publication Publication Date Title
PT830376E (pt) Processo de producao de eritropoietina isenta de proteinas animais
IL123641A0 (en) Circular dna molecule with conditional origin of replication method for preparing the same and use thereof in gene therapy
LU90855I2 (en) Proteine 1 osteogenique recombinante humaine: bmp-7 et ses d-riv-s pharmaceutiquement acceptables
FI873162A7 (fi) Menetelmä faktori VIII aktiviteetin omaavien proteiinien valmistamiseksi käyttäen mikrobi-isäntäsoluja; ekspressiovektorit, isäntäsolut, vasta-aineet
DK72593D0 (da) Rekombinant protein
ATE232237T1 (de) Herstellung von funktionellen, menschlichen urokinaseproteinen
NO911688L (no) Neurotrophin-3, en ny neurotrofisk faktor relatert til neurovekstfaktor og hjerne-avledet neurotrofisk faktor.
IT8119760A0 (it) Polipeptide prodotto microbiologicamente con la sequenza di aminoacidi dell'interferone umano, dna e plasmidi che codificano per questa sequenza, microorganismi che contengono queste informazioni genetiche e processo per la loro preparazione.
DE69334211D1 (de) Multidrug resistenz gen
ATE79403T1 (de) Herstellung von thrombin-inhibitoren.
DK619086D0 (da) Gm-csf-protein, derivater deraf, samt fremstilling og anvendelse af saadanne proteiner
SE8801701D0 (sv) Production technology based on enzymic method
FI90667C (fi) Menetelmä valmistaa uutta ihmisen tyypin I interferoniproteiinia
DE59810198D1 (de) Myc-bindende Zinkfinger-Proteine, ihre Herstellung und ihre Verwendung
DE3576361D1 (de) Rekombinante dna, damit transformierter mikroorganismus, und verfahren zur herstellung von menschlicher cu-zn superoxiddismutase unter verwendung des transformierten mikroorganismus.
EP0776972A4 (en) GENE CODING FOR IgG-Fc-BINDING PROTEIN
ATE316138T1 (de) Rekombinante expression von s-layer-proteinen
DE3584029D1 (de) Expressionsvektoren, dns-fragmente, peptide, wirte und verfahren zur herstellung von peptiden.
BR9711645A (pt) Método de superprodução de proteìna iniciada com um aminoácido diferente de metionina e proteìna produzida
EP0676413A3 (en) Interferon alpha / beta binding protein, its production and application.
ATE309371T1 (de) Protein mit dnase-aktivität
NO179453C (no) Fremgangsmåte for fremstilling av terapeutisk aktivt amphiregulin, vertscelle som produserer proteinet, rekombinant vektor inneholdt i vertscellen, samt nukleotidsekvens som koder for proteiner med amphiregulinaktivitet